CanSino Biologics (6185.HK/688185.CH) - Time to Offload; the Rally May Not Last Long
The fake news about China reopen and COVID-19 vaccine business are major driving force for the rally of CanSino’s share price, but such rally would...
422 Views
Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
709 Views
HSCI Index Rebalance: 29 Adds, 12 Deletes & Changes to Stock Connect
There are 29 adds & 12 deletes for the HSCI at the March rebal. 26 of the inclusions will join Southbound Stock Connect while all the deletes will...
656 Views
HSCI Index Rebalance and Stock Connect: Plenty of New Listings Should Be Included
There could be up to 34 adds and 22 deletes for the HSCI in March based on market cap, liquidity and prolonged suspensions. A lot of new listings,...
807 Views
Gushengtang IPO Trading - Priced at Top End with Lukewarm Subscription Rates
Gushengtang (GUS HK) raised around US$104m after pricing its IPO at HKD29.0/share, at the top end of the IPO price range.
610 Views